Skip to content

The Oncology Institute, Inc. TOI Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s finance lease, principal payments?
The Oncology Institute, Inc. (TOI) reported finance lease, principal payments of $9K in Q1 2026.
How has The Oncology Institute, Inc.'s finance lease, principal payments changed year-over-year?
The Oncology Institute, Inc.'s finance lease, principal payments decreased by 10.0% year-over-year, from $10K to $9K.
What is the long-term trend for The Oncology Institute, Inc.'s finance lease, principal payments?
Over 3 years (2022 to 2025), The Oncology Institute, Inc.'s finance lease, principal payments has grown at a -13.9% compound annual growth rate (CAGR), from $58K to $37K.